Orchestration across multi-agent systems and platforms is a critical concern — and a key differentiator for IT leaders hoping ...

UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. Click ...

Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

If you're looking for artificial intelligence (AI) stocks that have 10x growth potential within the next 10 years (meaning that they could turn $100,000 into $1 million), you're going to have to find ...

UiPath Inc. (NYSE: PATH) was recently added to the S&P MidCap 400 index, replacing Synovus Financial Corp., reflecting the automation company's increased scale and market presence. This index ...

Wondering if UiPath is still a smart way to play the AI and automation theme, or if the easy money has already been made? Here is a look at the numbers so you can decide if the current price really ...

UiPath Test Cloud recognized among top autonomous testing solutions with highest possible scores in vision, roadmap, and five other criteria UiPath (NYSE: PATH), a global leader in agentic automation, ...

Shares of UiPath rose after the company swung to a third-quarter profit on higher sales, helped by growing demand for its artificial intelligence offerings. The stock rose 4.5% to $15.53 in ...

View source version on businesswire.com: https://www.businesswire.com/news/home/20251203017308/en/ The articles, information, and content displayed on this webpage ...

UiPath Inc. (NYSE: PATH) stock jumped in Wednesday's extended trading after the company released its third quarter earnings report, beating expectations on the top and bottom lines. Here's a look at ...

UiPath is moving beyond simple, rule-based bots toward "agentic automation." Partnerships are helping to drive scalability of this evolving business. UiPath’s focus on security and transparency could ...